Patent ID: 8048860

Claim:
A method of treating a Th1-mediated disorder, comprising administering to a human subject in need thereof an effective amount of an isolated compound of formula I: wherein R 1 is H, alkyl, aryl, or cyclyl; R 2 is pyranose; R 3 is H or alkyl; m is 2, 3, 4, 5, or 6; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, 4; p is 1, 2, 3, or 4; and the Th1-mediated disorder is non-obese diabetes, Crohn's colitis, autoimmune hemolytic anemia, rheumatoid arthritis, autoimmune encephalitis, multiple sclerosis, or autoimmune myocarditis.